Navigation Links
LA BioMed to honor 3 of its legendary
Date:4/10/2008

nvolved in more than 20 grants and research awards to study new techniques for the treatment of intracranial aneurysms, arteriovenous malformations, cerebrovascular thrombolysis and angioplasty.

In 1997, he was honored by the Joint Section of Cerebrovascular Surgery with a Lifetime Achievement Award. In 1999, he received the Luessenhop Award as well as the exclusive Gold Medal from the American Society of Neuroradiology.

He is retired and lives with his wife, Donna, in Huntington Beach.

Dr. Turner

Dr. Turner first became interested in tropical diseases when he was in junior high school. As a medical student at UCLA, he worked with the faculty of the Division of Parasitology in the Department of Infectious Diseases. His summer parasitology research project in Guatemala was interrupted when he acquired paralytic poliomyelitis, an acute onset of paralysis.

After weeks in a Guatemalan hospital, he was transferred to the student health section of the UCLA Medical Center for rehabilitation. A year later, he joined the Class of 1958 for his senior year of medical school.

After an internal medicine internship at the UCLA Medical Center, Turner rejoined the Division of Parasitology as a faculty member and began his academic teaching career. He studied tropical medicine in Puerto Rico, Haiti, Mexico, South Africa, Kenya and Egypt. He also obtained a diploma in tropical medicine and hygiene from the London School of Hygiene and Tropical Medicine.

Dr. Turner returned to clinical internal medicine by joining the residency program at Harbor-UCLA Medical Center in 1964. He taught parasitology at UCLA until retirement, earning four "Golden Apple Teaching Awards" and an "Exceptional Quality Teaching Award" from the medical students. He also taught parasitology at the University of California, Irvine College of Medicine.

Dr. Turner served in several administrative roles at Harbor-UCLA Medical Center. Hes
'/>"/>

Contact: Laura Mecoy
Lmecoy@issuesmanagement.com
310-546-5860
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert

Page: 1 2 3 4 5

Related medicine news :

1. Response Biomedical Corporation Reports 2007 Financial Results
2. Response Biomedical Corporation Moves to New Facility
3. Response Biomedical Corp. - Year End 2007 Earnings Webcast and Conference Call - March 31, 2008
4. LA BioMed researcher says unexpected increase in cancer risk found
5. LA BioMed study finds hormone therapy increases frequency of abnormal mammograms, breast biopsies
6. BioMed Realty Trust Joint Venture Enters Into New $245 Million Construction Loan and Extends Term of Existing Loan Facility
7. Dr. Inder Verma named recipient of 2008 Vilcek Prize in biomedical science
8. 7th Annual Wiley Prize in Biomedical Sciences Awarded to Dr. Richard P. Lifton
9. Lung Cancer Alliance Urges Inclusion of $5 Billion for Biomedical Research in Economic Stimulus Package
10. BioMed Central bolsters radiology image collection
11. New nanotube findings by Stanford researchers give boost to potential biomedical applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015 LunaDress, with its top dressmaking technologies, ... Now, the business is showing its latest designs of wedding ... According to the company’s CEO, all the fresh new products ... big discounts, up to 80% off. All the clothes from ...
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who consistently delivers ... to have it lead the wedding dress industry into the ... dresses for the global market. , “The CEO of VogueQueen ... focuses on continuing the goal of operational excellence and giving ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 The federal court ... the U.S. District Court, Southern District of West Virginia has ... in that proceeding’s first bellwether trial. In an Order dated ... new trial after finding that C.R. Bard had not proven ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of ... area has treated just about every type of injury that can ... for those same twenty-plus years, the team at Doctors on ... the best possible doctor. With the combined breadth of ...
(Date:1/22/2015)... Weddingshe.com has added many trendy Champagne wedding dresses ... in the past three years. Today, the business announces a ... to the sales manager of the company, this is on ... This point can be reflected on the discounted wedding dresses ...
Breaking Medicine News(10 mins):Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2
... Milan, Altarum Institute VP and Chairman of the Black ... Speaker at Mexico City Business Council on AIDS, ... of,Altarum Institute and a prominent leader and advocate on ... on AIDS conference,Thursday, August 7th in Mexico City. The ...
... the wrong strains during flu season, the FDA should ... other changes to the vaccine composition, according to a ... of the Institute for Operations Research and the Management ... Influenza Vaccine Composition" is by Laura J. Kornish of ...
... Patient Safety Technology, HONOLULU, Aug. 5 ... Queen,s Medical Center will equip 100 additional ... Vigilance Systems,(LifeBed), bringing the total number LifeBed,s ... transforms any bed into a LifeBed, which,invisibly ...
... ... - Adjusted Diluted EPS(1) ... Full-Year 2008 Earnings Estimate - - Conference Call Scheduled ... WST ) today announced results for the second quarter,of 2008. Reported diluted earnings per share of $0.82 ...
... MONTREAL, Aug. 5 /PRNewswire-FirstCall/ - CryoCath(R) Technologies,Inc., the ... announced financial results for the third quarter, ended,June 30, ... Highlights: - Grew revenue in Q3 2008 ... comparable electrophysiology (EP) revenue in Q3 ...
... Backlog Reaches $72 ... Million ... Recently-introduced Odyssey System Building Strong Market Momentum, ST. LOUIS, Aug. 5 ... 2008. Revenue for the recent second quarter increased 36% to $10.7,million compared with ...
Cached Medicine News:Health News:New decision model seeks to avert flu vaccine mismatch of 2007-2008 season 2Health News:Hoana Medical Expands Partnership With The Queen's Medical Center to Improve Patient Safety 2Health News:Hoana Medical Expands Partnership With The Queen's Medical Center to Improve Patient Safety 3Health News:West Announces Second Quarter 2008 Results 2Health News:West Announces Second Quarter 2008 Results 3Health News:West Announces Second Quarter 2008 Results 4Health News:West Announces Second Quarter 2008 Results 5Health News:West Announces Second Quarter 2008 Results 6Health News:West Announces Second Quarter 2008 Results 7Health News:West Announces Second Quarter 2008 Results 8Health News:West Announces Second Quarter 2008 Results 9Health News:West Announces Second Quarter 2008 Results 10Health News:West Announces Second Quarter 2008 Results 11Health News:West Announces Second Quarter 2008 Results 12Health News:West Announces Second Quarter 2008 Results 13Health News:West Announces Second Quarter 2008 Results 14Health News:West Announces Second Quarter 2008 Results 15Health News:West Announces Second Quarter 2008 Results 16Health News:West Announces Second Quarter 2008 Results 17Health News:West Announces Second Quarter 2008 Results 18Health News:West Announces Second Quarter 2008 Results 19Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 2Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 3Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 4Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 5Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 6Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 7Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 8Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 9Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 10Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 11Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 12Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 13Health News:Stereotaxis Reports Record Second Quarter Revenue 2Health News:Stereotaxis Reports Record Second Quarter Revenue 3
(Date:1/23/2015)... 2015 Gem Pharmaceuticals announced today that the initial ... the Company,s Phase 2 clinical trial.  This open-label study ... compound, GPX-150 (an investigational medication), in approximately 30 adults ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/22/2015)... Jan. 22, 2015  Uroplasty, Inc. (NASDAQ: UPI ), ... innovative proprietary products to treat voiding dysfunctions, today reported ... 31, 2014.  Global revenue for the Company,s ... million, a new quarterly revenue record, as compared to ...
(Date:1/22/2015)... SAN DIEGO , Jan. 22, 2015  Profil Institute ... focused on diabetes and obesity, announced today a new ... Drug Development,  published by Springer, a leading global scientific ... extensively analyze and illustrate techniques for use in early ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3
... PARSIPPANY, N.J., July 7, 2011 Watson Pharmaceuticals, Inc. ... United States Court of Appeals for the Federal Circuit ... Southern District of Florida,s February 2011 decision that Watson,s ... Mucinex(R) DM (Dextromethorphan HBr/ Guaifenesin) Extended-Release products do not ...
... 2011 Watson Pharmaceuticals, Inc. (NYSE: ... Laboratories, Inc., filed an Abbreviated New Drug Application ... (FDA) seeking approval to market lisdexamfetamine dimesylate capsules. ... of Shire LLC,s Vyvanse®. Vyvanse® is a prescription ...
Cached Medicine Technology:Watson Confirms Favorable Appeals Court Decision in Mucinex(R) Patent Suit 2Watson Confirms Vyvanse® Patent Challenge 2
... from medium compression weight ... provides upper back compression ... the arms. Arm length ... Wonderfabric™ unraveling. Velcro® closing ...
Fully lined with cotton material for extra softness against patients skin. The 3 single adjustable soft Velcro® band provides,downward pressure preventing implants from moving upward or to the s...
This compression garment can be used for Breast Augmentation, Augmentation Mammaplasty, Trans Umbilical Breast Augmentation, Transaxillary Submuscular Augmentation....
Provides gentle compression above and below implants...
Medicine Products: